Screener
Schrodinger SDGR Contribution — Deferred Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Schrodinger in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The source filing: Schrodinger’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001490978-26-000068
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Deferred revenue, short-term: | ||
| Software products and services | 52,310 | 66,695 |
| Drug discovery | 48,322 | 46,027 |
| Contribution | 4,141 | 131 |
| Deferred revenue, long-term: | ||
| Software products and services | 4,303 | 7,333 |
| Drug discovery | 40,849 | 71,544 |
| Contribution | — | — |
Item 1. Financial Statements.
FAQ
- What is Schrodinger's contribution — deferred revenue?
- Schrodinger (SDGR) reported contribution — deferred revenue of $4.14M in Q2 2026.
- What does contribution — deferred revenue mean?
- Represents payments received from customers for services or products that have not yet been fully delivered or earned. This serves as a key indicator of future revenue potential and customer commitment.
Ask your AI about Schrodinger's contribution — deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude